Literature DB >> 8753814

Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein.

Y Gwack1, D W Kim, J H Han, J Choe.   

Abstract

The Hepatitis C Virus (HCV) NS3 protein has RNA binding activity, RNA-stimulated NTPase activity, and RNA helicase activity. The RNA binding activity of the C-terminal domain of the HCV NS3 protein is less sensitive to pH, KCl, and MgCl2 than NTPase and the RNA helicase activity. The overall order of the binding of homoribopolymer for the NS3 protein was poly(U) > > poly(A) > poly(G), poly(C). The minimal RNA binding size of the HCV NS3 protein was determined using a gel retardation assay and is estimated between 7 nt and 20 nt. The HCV RNA helicase unwinds RNA/DNA heteroduplexes as well as RNA/RNA duplexes and it catalytically translocates in the 3' to 5' direction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753814     DOI: 10.1006/bbrc.1996.1225

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A.

Authors:  Ting Xu; Aruna Sampath; Alex Chao; Daying Wen; Max Nanao; Patrick Chene; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Structure-based mutational analysis of the NS3 helicase from dengue virus.

Authors:  Aruna Sampath; Ting Xu; Alex Chao; Dahai Luo; Julien Lescar; Subhash G Vasudevan
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 3.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro.

Authors:  Bartek Sikora; Yingfeng Chen; Cheryl F Lichti; Melody K Harrison; Thomas A Jennings; Yong Tang; Alan J Tackett; John B Jordan; Joshua Sakon; Craig E Cameron; Kevin D Raney
Journal:  J Biol Chem       Date:  2008-02-18       Impact factor: 5.157

5.  Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.

Authors:  Ping-Kun Hsieh; Shin C Chang; Chu-Chun Huang; Ting-Ting Lee; Ching-Wen Hsiao; Yi-Hen Kou; I-Yin Chen; Chung-Ke Chang; Tai-Huang Huang; Ming-Fu Chang
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

7.  Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.

Authors:  Simon Despins; Moheshwarnath Issur; Isabelle Bougie; Martin Bisaillon
Journal:  Nucleic Acids Res       Date:  2010-04-25       Impact factor: 16.971

8.  The nonstructural protein 2C of a Picorna-like virus displays nucleic acid helix destabilizing activity that can be functionally separated from its ATPase activity.

Authors:  Zhenyun Cheng; Jie Yang; Hongjie Xia; Yang Qiu; Zhaowei Wang; Yajuan Han; Xiaoling Xia; Cheng-Feng Qin; Yuanyang Hu; Xi Zhou
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

9.  An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-D-ribofuranoside.

Authors:  Ravi K Ujjinamatada; Andrea Baier; Peter Borowski; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2007-01-27       Impact factor: 2.823

10.  Selection of functional variants of the NS3-NS4A protease of hepatitis C virus by using chimeric sindbis viruses.

Authors:  G Filocamo; L Pacini; C Nardi; L Bartholomew; M Scaturro; P Delmastro; A Tramontano; R De Francesco; G Migliaccio
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.